Analysts are estimating that Quest Diagnostics will report an earnings per share (EPS) of $2.57.
Investors in Quest Diagnostics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Past Earnings Performance
In the previous earnings release, the company beat EPS by $0.06, leading to a 0.42% increase in the share price the following trading session.
Here's a look at Quest Diagnostics's past performance and the resulting price change:
Quarter
Q1 2025
Q4 2024
Q3 2024
Q2 2024
EPS Estimate
2.15
2.18
2.26
2.34
EPS Actual
2.21
2.23
2.30
2.35
Price Change %
0.0%
-7.000000000000001%
1.0%
-2.0%
Stock Performance
Shares of Quest Diagnostics were trading at $166.91 as of July 18. Over the last 52-week period, shares are up 11831.9%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Insights Shared by Analysts on Quest Diagnostics
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Quest Diagnostics.
The consensus rating for Quest Diagnostics is Neutral, based on 7 analyst ratings. With an average one-year price ...